BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 31148905)

  • 1. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
    Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
    World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
    He Q; Ma L; Li Y; Li G
    BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study.
    Yu P; Du Y; Xu Z; Huang L; Cheng X
    World J Surg Oncol; 2019 Feb; 17(1):28. PubMed ID: 30728027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
    Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Wada T; Yoshikawa T; Sekine S; Kamiya A; Hayashi T; Otsuki S; Yamagata Y; Katai H
    Eur J Surg Oncol; 2022 Feb; 48(2):333-338. PubMed ID: 34284903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute.
    Abdelhamed MA; Abdellatif A; Touny A; Mahmoud AM; Ahmed IS; Maamoun S; Shalaby M
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):10. PubMed ID: 32372263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.
    Lee JH; Paik YH; Lee JS; Song HJ; Ryu KW; Kim CG; Park SR; Kook MC; Kim YW; Bae JM
    Ann Surg Oncol; 2006 Sep; 13(9):1163-7. PubMed ID: 16952027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
    Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver.
    Akita M; Maeda E; Ishida R; Morikawa T; Nishimura T; Abe K; Kozuki A; Tanaka T; Kaneda K
    Langenbecks Arch Surg; 2022 Nov; 407(7):3141-3146. PubMed ID: 35978050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer.
    Endo S; Ikenaga M; Yamada T; Tamura S; Sasaki YO
    Anticancer Res; 2020 Apr; 40(4):2351-2357. PubMed ID: 32234937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical choice of proximal gastric cancer in China: a retrospective study of a 30-year experience from a single center in China.
    Zhu Z; Wu P; Du N; Li K; Huang B; Wang Z; Xu H
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1123-1128. PubMed ID: 31687853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.